Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors.

Eur J Med Chem

University Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre Le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 Rue J.-B. Clément, Châtenay-Malabry F-92296, France. Electronic address:

Published: August 2014

A series of substituted coumarins1-10 was designed and synthesized as a novel class of 4TCNA analogues. Compound 2a showed excellent antiproliferative activity with mean GI50 values at a micromolar level in a diverse set of human cancer cells (GI50 = 2-30 μM) and induced a high apoptosis level in MCF-7 breast cancer cell line. The molecular signature of hsp90 inhibition was assessed by depletion of the Erα hsp90 client protein.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2014.06.067DOI Listing

Publication Analysis

Top Keywords

antiproliferative activity
8
synthesis antiproliferative
4
activity novobiocin
4
novobiocin analogues
4
analogues potential
4
potential hsp90
4
hsp90 inhibitors
4
inhibitors series
4
series substituted
4
substituted coumarins1-10
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!